KNSA Market Cap & Key Metrics
Kiniksa Pharmaceuticals, Ltd.
$78.84
+$0.31(+0.39%)
61
Overall
40
Value
63
Tech
81
Quality
Market Cap
$6.15B
Volume
576.51K
52W Range
$35.20 - $82.94
Target Price
$96.11
KNSA market cap is $6.15B. This page lists Kiniksa Pharmaceuticals, Ltd.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
KNSA Key Metrics
- Market cap
- $6.15B
- P/E ratio (current-year EPS estimate)
- 57.55
- EPS estimate, current year
- $1.37
- EPS growth, 3-year
- -32.83%
- Value score
- 40
- Quality score
- 81
- Technical score
- 63
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $677.56M | $423.24M | $270.26M | $220.18M | $38.54M |
| EBITDA | $90.42M | -$34.46M | -$14.31M | $11.03M | -$154.28M |
| EPS | $0.80 | $-0.60 | $0.20 | $2.64 | $-2.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $78.84 | +0.4% | 576.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals, Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW